ZMAT3
Basic information
Region (hg38): 3:178960121-179072215
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZMAT3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 14 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 14 | 2 | 0 |
Variants in ZMAT3
This is a list of pathogenic ClinVar variants found in the ZMAT3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-179025045-T-C | not specified | Likely benign (Jan 05, 2022) | ||
3-179025054-C-T | not specified | Uncertain significance (Jul 26, 2021) | ||
3-179025055-G-A | not specified | Uncertain significance (Jun 29, 2023) | ||
3-179025072-C-T | not specified | Uncertain significance (Jul 05, 2023) | ||
3-179025202-G-A | not specified | Uncertain significance (Nov 12, 2021) | ||
3-179027464-A-T | not specified | Uncertain significance (Aug 23, 2021) | ||
3-179027477-C-T | not specified | Uncertain significance (Jan 26, 2022) | ||
3-179027772-G-A | not specified | Uncertain significance (Apr 05, 2023) | ||
3-179030884-G-A | not specified | Uncertain significance (Jan 05, 2022) | ||
3-179030965-T-C | not specified | Uncertain significance (Apr 05, 2023) | ||
3-179067524-C-T | not specified | Uncertain significance (Dec 22, 2023) | ||
3-179067545-G-T | not specified | Uncertain significance (Aug 02, 2021) | ||
3-179067559-T-G | not specified | Uncertain significance (Nov 06, 2023) | ||
3-179067571-C-T | Malignant tumor of prostate | Uncertain significance (-) | ||
3-179067572-A-T | not specified | Likely benign (Nov 18, 2022) | ||
3-179067641-G-C | not specified | Uncertain significance (Jun 01, 2023) | ||
3-179067731-C-T | not specified | Uncertain significance (Dec 28, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZMAT3 | protein_coding | protein_coding | ENST00000311417 | 5 | 55057 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000190 | 0.907 | 125734 | 0 | 14 | 125748 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.778 | 138 | 166 | 0.830 | 0.00000947 | 1877 |
Missense in Polyphen | 43 | 63.592 | 0.67619 | 701 | ||
Synonymous | 1.06 | 52 | 62.7 | 0.830 | 0.00000346 | 571 |
Loss of Function | 1.52 | 8 | 14.2 | 0.564 | 8.44e-7 | 157 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000178 | 0.000177 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000529 | 0.0000527 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a bona fide target gene of p53/TP53. May play a role in the TP53-dependent growth regulatory pathway. May contribute to TP53-mediated apoptosis by regulation of TP53 expression and translocation to the nucleus and nucleolus. {ECO:0000269|PubMed:11571644}.;
- Pathway
- p53 signaling pathway - Homo sapiens (human);miRNA regulation of p53 pathway in prostate cancer
(Consensus)
Recessive Scores
- pRec
- 0.115
Intolerance Scores
- loftool
- 0.732
- rvis_EVS
- -0.45
- rvis_percentile_EVS
- 24
Haploinsufficiency Scores
- pHI
- 0.123
- hipred
- N
- hipred_score
- 0.369
- ghis
- 0.639
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.914
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Zmat3
- Phenotype
Gene ontology
- Biological process
- apoptotic process;cellular response to DNA damage stimulus;protein transport;regulation of growth;positive regulation of apoptotic process
- Cellular component
- nucleoplasm;nucleolus;plasma membrane
- Molecular function
- RNA binding;protein binding;zinc ion binding